DNA Synthesis Market Analysis and Forecast, 2024-2028 - Rising Investments in Genomics R&D and Advances in Sequencing Technologies Driving the Industry at 18.1% CAGR
15. November 2024 07:48 ET
|
Research and Markets
Dublin, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The "DNA Synthesis Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The DNA synthesis market is forecasted to grow by USD 6.52...
Antisense & RNAi Therapeutics Market Overview 2024-2030 - Global Antisense & RNAi Therapeutics Market Forecast to Reach $14.4 Billion by 2030
12. November 2024 05:33 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for...
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
07. Oktober 2024 08:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17. September 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Synthetic Biology Market Forecast Report to 2029: Focus on Market Opportunities - Use of Machine Learning in Synthetic Biology and Increasing Demand for Fuel Alternatives
16. September 2024 08:26 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for synthetic biology was valued...
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
15. August 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
Global Oligonucleotide Synthesis Industry Research 2024-2035: Partnerships and Collaborations Fueling Market Growth, Close to 300 Trials Being Evaluated to Treat Myriad of Disease Indications
16. Juli 2024 04:01 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Industry Trends and Global Forecasts, Till 2035 - Application Area, Type of Product Synthesized, Type of...
Global Large Molecule Bioanalytical Technologies Market Research 2024: Innovative Analytical Techniques Driving Progress, Integration of AI in Bioanalysis - Forecasts to 2031
27. Juni 2024 06:58 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Large Molecule Bioanalytical Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Exosome Therapeutics Pipeline research 2024
19. Juni 2024 07:45 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Exosomes - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An array of drugs is currently moving through various...
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
15. April 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors